Verition Fund Management LLC Spring Works Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 158,784 shares of SWTX stock, worth $7.41 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
158,784Holding current value
$7.41 Million% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding SWTX
# of Institutions
361Shares Held
63.1MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$262 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$136 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$121 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$100 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.91B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...